How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

630 results for

Dyspepsia in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02567578 Recruitment Status : Suspended (due to dose re-selection) First Posted : October 5, 2015 Last Update Posted : September 7

2015 Clinical Trials

22. Cognitive Modulation of Dyspeptic Symptom During Food Ingestion in Functional Dyspepsia Patients Cognitive Modulation

Cognitive Modulation of Dyspeptic Symptom During Food Ingestion in Functional Dyspepsia Patients Cognitive Modulation Cognitive Modulation of Dyspeptic Symptom During Food Ingestion in Functional Dyspepsia Patients Cognitive Modulation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Cognitive Modulation of Dyspeptic Symptom During Food Ingestion in Functional Dyspepsia Patients Cognitive Modulation The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02618070 Recruitment Status : Completed First Posted

2015 Clinical Trials

23. Functional Dyspepsia and Symptom Perception

and rivaroxaban), and clopidogrel (Patients or healthy controls using calcium carbasalate (acetylsalicylic acid 100mg 1dd1) are eligible to participate in the study. Patients or healthy controls using higher doses of calcium carbasalate will be excluded from the study). Dieting Pregnancy or lactation Smoking Excessive alcohol use (>20 alcoholic consumptions/week) and inability to avoid use of alcohol in the 2 days prior to endoscopy and multi-sugar test Functional dyspepsia patients Inclusion criteria (...) Functional Dyspepsia and Symptom Perception Functional Dyspepsia and Symptom Perception - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Functional Dyspepsia and Symptom Perception The safety and scientific

2015 Clinical Trials

24. Gastric Activity and Gastrointestinal Peptides in Patients With Functional Dyspepsia

Gastric Activity and Gastrointestinal Peptides in Patients With Functional Dyspepsia Gastric Activity and Gastrointestinal Peptides in Patients With Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Gastric Activity and Gastrointestinal Peptides in Patients With Functional Dyspepsia (DYSMOT-RIII) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02113527 Recruitment Status : Completed First Posted : April 14, 2014 Last Update Posted : September 2, 2015 Sponsor: Azienda Ospedaliera

2014 Clinical Trials

25. Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method

Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02151708 Recruitment Status : Unknown Verified November 2014 by Poong-Lyul Rhee

2014 Clinical Trials

26. SSRI Study for Functional Dyspepsia (SS)

Organic disease as cause of dyspepsia H. pylori infection Use of PPI or NSAID in the past 4 weeks Pregnancy Known hypersensitivity to SSRI Unable to read Chinese or illiterate Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02153567 Locations Layout (...) SSRI Study for Functional Dyspepsia (SS) SSRI Study for Functional Dyspepsia (SS) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. SSRI Study for Functional Dyspepsia (SS) The safety and scientific validity

2014 Clinical Trials

27. Sildenafil in Pregnancy: A Systematic Review of Maternal Tolerance and Obstetric and Perinatal Outcomes. (PubMed)

Sildenafil in Pregnancy: A Systematic Review of Maternal Tolerance and Obstetric and Perinatal Outcomes. This systematic review evaluates maternal tolerance and obstetric and perinatal outcomes following sildenafil citrate (SC) use in human pregnancy.Scopus, PubMed, Cochrane Library, Web of Science, Embase, and Google Scholar were searched. Relevant full-text studies including case series and reports in English were included. Publications were excluded if the pregnancy was terminated or if SC (...) was used only at conception.Sixteen studies were included (n = 165). Indications for use and outcomes were variably reported. Maternal outcomes reported were headache (45.8%, 49/107), visual disturbances (17.3%, 14/81), dyspepsia/epigastric pain (15.8%, 15/95), and hypotension (0%, 0/39). There were more caesarean (83.3%, 55/66) than vaginal deliveries (16.7%, 11/66) and postpartum haemorrhage occurred in 3.9% (3/76) of women exposed to SC. Neonatal outcomes including nursery admission (67.3%, 35/52

Full Text available with Trip Pro

2016 Fetal diagnosis and therapy

28. Step-up and step-down treatment strategies did not differ for symptom relief at 6 months in new onset dyspepsia

patients ⩾18 years of age (54% women) who visited their general practitioner for new onset dyspepsia (pain or discomfort in upper abdomen and originating in upper gastrointestinal tract). Exclusion criteria included gastroscopy in the past year, use of prescribed acid suppressive medication in the past 3 months, alarm symptoms (dysphagia, weight loss, anaemia, or haematemesis), pregnancy, or insufficient knowledge of Dutch. Intervention: step-up treatment (n = 341) given in 3 four-week steps: (1 (...) Step-up and step-down treatment strategies did not differ for symptom relief at 6 months in new onset dyspepsia Step-up and step-down treatment strategies did not differ for symptom relief at 6 months in new onset dyspepsiaCommentary | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your

2009 Evidence-Based Medicine (Requires free registration)

29. Itch in pregnancy

Itch in pregnancy Itch in pregnancy - NICE CKS Share Itch in pregnancy: Summary Itch in pregnancy may be caused by a pre-existing condition, or a condition specific to pregnancy. The most common pregnancy-related causes of itch are: Obstetric cholestasis (also known as 'intrahepatic cholestasis of pregnancy') — which does not present with a rash. Polymorphic eruption of pregnancy, atopic eruption of pregnancy, and pemphigoid gestationis — all of which present with a rash. Itch occurs in about 1 (...) in 5 pregnant women. Obstetric cholestasis is the main cause of itch without a rash in pregnancy. The itch (often severe) usually starts abruptly in the third trimester on the soles of the feet and palms of the hands, and spreads to become more generalized. It is often worse at night. Obstetric cholestasis generally poses no risk to the pregnant woman. Although it is associated with an increased risk of stillbirth, this appears to be only slightly raised above background rates with specialist

2015 NICE Clinical Knowledge Summaries

30. Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia

Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01851863 Recruitment Status : Completed First Posted : May 13, 2013 Results First Posted : February 23, 2015 Last Update Posted : February 23, 2015 Sponsor: RenJi Hospital

2013 Clinical Trials

31. Ghrelin and Gastric Emptying in Children With Functional Dyspepsia

Ghrelin and Gastric Emptying in Children With Functional Dyspepsia Ghrelin and Gastric Emptying in Children With Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Ghrelin and Gastric (...) Emptying in Children With Functional Dyspepsia (GHR) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01591174 Recruitment Status : Unknown Verified February 2015 by Nadia Hijaz, Children's Mercy Hospital Kansas City. Recruitment status was: Active, not recruiting First Posted : May 3, 2012 Last Update

2012 Clinical Trials

32. The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia

: No Criteria Inclusion Criteria: aged 18-45 years with symptoms of dyspepsia, no evidence of organic disease. Exclusion Criteria: Patients with alarm symptoms, Severe concomitant illness, Pregnancy or lactation, Alcohol or drug abuse, Use of aspirin or other non-steroidal anti-inflammatory drugs antibiotics, H2 receptor blockers, bismuth, or proton pump inhibitors in the preceding two weeks Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you (...) The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2012 Clinical Trials

33. Comparison of Pantoprazole and Ranitidine in Dyspepsia

Comparison of Pantoprazole and Ranitidine in Dyspepsia Comparison of Pantoprazole and Ranitidine in Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Comparison of Pantoprazole and Ranitidine (...) in Dyspepsia The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01737840 Recruitment Status : Completed First Posted : November 30, 2012 Results First Posted : July 23, 2015 Last Update Posted : July 23, 2015 Sponsor: Akdeniz University Information provided by (Responsible Party): Akdeniz University Study

2012 Clinical Trials

34. Rifaximin for Functional Dyspepsia

Rifaximin for Functional Dyspepsia Rifaximin for Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Rifaximin for Functional Dyspepsia The safety and scientific validity of this study (...) is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01643083 Recruitment Status : Completed First Posted : July 17, 2012 Last Update Posted : December 2, 2015 Sponsor: The University of Hong Kong Information provided by (Responsible Party): LEUNG Wai Keung, The University of Hong Kong Study Details Study Description Go to Brief Summary: Functional dyspepsia is a very

2012 Clinical Trials

35. Plasma Levels of Glucagon-like Peptide-2 and Dyspepsia in Patients With Extraintestinal Cancer During Chemotherapy

Plasma Levels of Glucagon-like Peptide-2 and Dyspepsia in Patients With Extraintestinal Cancer During Chemotherapy Plasma Levels of Glucagon-like Peptide-2 and Dyspepsia in Patients With Extraintestinal Cancer During Chemotherapy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Plasma Levels of Glucagon-like Peptide-2 and Dyspepsia in Patients With Extraintestinal Cancer During Chemotherapy The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01382667 Recruitment Status : Completed First Posted : June 27

2011 Clinical Trials

36. BRAVO Study for Functional Dyspepsia

BRAVO Study for Functional Dyspepsia BRAVO Study for Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. BRAVO Study for Functional Dyspepsia (BD) The safety and scientific validity (...) : Background: Functional dyspepsia is one of the commonest digestive disorders. The pathophysiology of functional dyspepsia is uncertain. Proton pump inhibitor (PPI) has been recommended as the first line treatment for functional dyspepsia. However, the results on effectiveness of PPI are conflicting and it has been suggested that PPI is only effective for acid-related symptoms. The investigators plan to use a wireless pH monitoring system positioned at the junction of esophagus and stomach to evaluate

2011 Clinical Trials

37. The Clinical Significance of Acid Rebound in Functional Dyspepsia

The Clinical Significance of Acid Rebound in Functional Dyspepsia The Clinical Significance of Acid Rebound in Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. The Clinical Significance (...) of Acid Rebound in Functional Dyspepsia (CLARIFY) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01373970 Recruitment Status : Terminated First Posted : June 15, 2011 Last Update Posted : December 6, 2013 Sponsor: Zealand University Hospital Information provided by (Responsible Party): Anders Bergh

2011 Clinical Trials

38. Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia

; Scheduled for endoscopy to evaluate dyspepsia following non-response to standard acid reduction therapy; >20kg/45 lbs. and, Group 2 (Controls): Ages 8-17 inclusive; >20kg/45 lbs. Exclusion Criteria: Both groups: Previous abdominal surgery; <20 kg/45 lbs.: Pregnancy; Chronic disease requiring regular medical care (e.g. diabetes mellitus, juvenile rheumatoid arthritis, cystic fibrosis, cancer); or, Non-English speaking. Controls: Recent history (within 6 months) of abdominal pain, nausea, vomiting (...) Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2011 Clinical Trials

39. Use of Maytenus Ilicifolia in the Treatment of Dyspepsia

, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: age > 18 years being literate diagnosis of dyspepsia initial SODA score > or = 25 Exclusion Criteria: pregnancy lactation allergy to Maytenus species fail to use the drug for 3 uninterrupted weeks new onset serious adverse events, attributable to the drug patient's request Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your (...) Use of Maytenus Ilicifolia in the Treatment of Dyspepsia Use of Maytenus Ilicifolia in the Treatment of Dyspepsia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Use of Maytenus Ilicifolia in the Treatment

2011 Clinical Trials

40. Obstetrical catastrophe averted: successful outcome of an abdominal pregnancy. (PubMed)

malformations [3,7]. Patients of abdominal pregnancy can have variable clinical presentation, and physical examination may be inconclusive for making diagnosis [7,8]. Clinical features like irregular bleeding per vaginum, abdominal pain, dyspepsia, altered bowel habits, malpresentation, and extremely anteriorly placed cervix should raise the suspicion [2,3,8,9]. Diagnostic challenge with oxytocin stimulation, abdominal x-ray, hysterosalpingography, and ultrasonography has been used as tools to assist (...) Obstetrical catastrophe averted: successful outcome of an abdominal pregnancy. Abdominal pregnancy is defined as an implantation in peritoneal cavity, exclusive of tubal, ovarian, or intraligmentary pregnancy.These pregnancies are rarely encountered and can go undiagnosed until advanced period of gestation [1]. Frequency of abdominal pregnancy has been directly related to the frequency of ectopic gestation as constituting 2% of ectopics and nearly 0.01% of all pregnancies [2-4

2014 American Journal of Emergency Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>